Prostate Cancer
Location and Types of Treatment for Prostate Cancer After the Veterans Choice Program Implementation.
October 25, 2023
Sumitomo Pharma Announces Authorization in Canada of ORGOVYX® (relugolix) for the Treatment of Men with Advanced Prostate Cancer
October 23, 2023
PSMA-PET in Addition to mpMRI and Biopsies to Select Prostate Cancer Patients for Focal Therapy.
October 23, 2023
Long-Term Nephrotoxicity of 177Lu-PSMA Radioligand Therapy.
October 23, 2023
Analysis of active surveillance uptake for localized prostate cancer in Quebec in 2016: A Canadian bicentric study and comparison with 2010 data.
October 23, 2023